Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Panduri

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|August 26, 2023
Assessment and Monitoring of Nail Psoriasis with Ultra-High Frequency Ultrasound: Preliminary ResultsAlessandra Michelucci, Valentina Dini, Giorgia Salvia, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 24, 2017
The management of moderate-to-severe chronic plaque psoriasisAnnalisa Tonini, Salvatore Panduri, Angelo M D' Erme, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|February 2, 2021
Ultra-high-frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatmentValentina Dini, Agata Janowska, Francesco Faita, et al.
Advances in Skin & Wound Care|April 22, 2024
Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma GangrenosumAlessandra Michelucci, Flavia Manzo Margiotta, Giammarco Granieri, et al.
Expert Opinion on Biological Therapy|November 3, 2025
Real-world effectiveness and predictors of complete skin clearance (PASI 100) with anti-IL-23 monoclonal antibodies in moderate-to-severe psoriasis: a retrospective cohort studyAlessandra Michelucci, Giorgia Salvia, Nicolò Mori, et al.
Expert Opinion on Biological Therapy|March 20, 2025
Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-IL 17 and anti-IL 23 monoclonal antibodies: a retrospective observational studyAlessandra Michelucci, Flavia Manzo Margiotta, Filippo Fanetti, et al.
The International Journal of Lower Extremity Wounds|January 4, 2023
An Integrated Systemic and Local Wound Management in Recalcitrant Pyoderma GangrenosumGiorgia Salvia, Alessandra Michelucci, Giammarco Granieri, et al.
Scientific Reports|July 5, 2025
Assessing the burden of dermatological diseases on work life from a gender perspectiveMartina Padovan, Bianca Benedetta Benincasa, Salvatore Panduri, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 9, 2025
Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric studyFlavia Manzo Margiotta, Cristian Fidanzi, Simone Pardossi, et al.
Dermatologic Therapy|September 24, 2017
Treatment of psoriasis with topical agents: Recommendations from a Tuscany ConsensusAndrea Chiricozzi, Nicola Pimpinelli, Federica Ricceri, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|August 26, 2023
Assessment and Monitoring of Nail Psoriasis with Ultra-High Frequency Ultrasound: Preliminary ResultsAlessandra Michelucci, Valentina Dini, Giorgia Salvia, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|May 24, 2017
The management of moderate-to-severe chronic plaque psoriasisAnnalisa Tonini, Salvatore Panduri, Angelo M D' Erme, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|February 2, 2021
Ultra-high-frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatmentValentina Dini, Agata Janowska, Francesco Faita, et al.
Advances in Skin & Wound Care|April 22, 2024
Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma GangrenosumAlessandra Michelucci, Flavia Manzo Margiotta, Giammarco Granieri, et al.
Expert Opinion on Biological Therapy|November 3, 2025
Real-world effectiveness and predictors of complete skin clearance (PASI 100) with anti-IL-23 monoclonal antibodies in moderate-to-severe psoriasis: a retrospective cohort studyAlessandra Michelucci, Giorgia Salvia, Nicolò Mori, et al.
Expert Opinion on Biological Therapy|March 20, 2025
Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-IL 17 and anti-IL 23 monoclonal antibodies: a retrospective observational studyAlessandra Michelucci, Flavia Manzo Margiotta, Filippo Fanetti, et al.
The International Journal of Lower Extremity Wounds|January 4, 2023
An Integrated Systemic and Local Wound Management in Recalcitrant Pyoderma GangrenosumGiorgia Salvia, Alessandra Michelucci, Giammarco Granieri, et al.
Scientific Reports|July 5, 2025
Assessing the burden of dermatological diseases on work life from a gender perspectiveMartina Padovan, Bianca Benedetta Benincasa, Salvatore Panduri, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|January 9, 2025
Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric studyFlavia Manzo Margiotta, Cristian Fidanzi, Simone Pardossi, et al.
Dermatologic Therapy|September 24, 2017
Treatment of psoriasis with topical agents: Recommendations from a Tuscany ConsensusAndrea Chiricozzi, Nicola Pimpinelli, Federica Ricceri, et al.
Pageof 3